Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Eddingpharm and Chiesi Farmaceutici Form Asthma Drug JV

publication date: Apr 15, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Eddingpharm has formed a JV with Chiesi Farmaceutici that will market two of Chiesi’s asthma drugs in China. Eddingpharm distributes western drugs in China. The JV is owned 51% by Eddingpharm and 49% by Chiesi Farmaceutici. The two respiratory products were recently given Imported Drug Licenses by the SFDA, and the JV expects to begin marketing them in mid-2013. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...